+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Hemostasis Rapid Tests & Point of Care (POC) - Medical Devices Pipeline Assessment, 2019

  • ID: 4856477
  • Report
  • November 2019
  • Region: Global
  • 31 pages
  • GlobalData
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 3

FEATURED COMPANIES

  • Atomo Diagnostics Pty Ltd
  • Cascade Metrix LLC
  • Edan Instruments Inc
  • Emosis SAS
  • Helena Laboratories Corp
  • Universal Biosensors Inc
  • MORE
Hemostasis Rapid Tests & Point of Care (POC) - Medical Devices Pipeline Assessment, 2019

Summary
The author's Medical Devices sector report, “Hemostasis Rapid Tests & Point of Care (POC) - Medical Devices Pipeline Assessment, 2019 provides an overview of Hemostasis Rapid Tests & Point of Care (POC) currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Hemostasis Rapid Tests & Point of Care (POC) pipeline products.
This report is prepared using data sourced from in-house databases, secondary and primary research by The author's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Hemostasis Rapid Tests & Point of Care (POC) under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Hemostasis Rapid Tests & Point of Care (POC) and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to buy
The report enables you to:
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Hemostasis Rapid Tests & Point of Care (POC) under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Atomo Diagnostics Pty Ltd
  • Cascade Metrix LLC
  • Edan Instruments Inc
  • Emosis SAS
  • Helena Laboratories Corp
  • Universal Biosensors Inc
  • MORE

1.1 List of Tables
1.2 List of Figures

2 Introduction
2.1 Hemostasis Rapid Tests & Point of Care (POC) Overview

3 Products under Development
3.1 Hemostasis Rapid Tests & Point of Care (POC) Pipeline Products by Stage of Development
3.2 Hemostasis Rapid Tests & Point of Care (POC) Pipeline Products by Territory
3.3 Hemostasis Rapid Tests & Point of Care (POC) Pipeline Products by Regulatory Path
3.4 Hemostasis Rapid Tests & Point of Care (POC) Pipeline Products by Estimated Approval Date

4 Hemostasis Rapid Tests & Point of Care (POC) Pipeline Products under Development by Companies
4.1 Hemostasis Rapid Tests & Point of Care (POC) Companies - Pipeline Products by Stage of Development
4.2 Hemostasis Rapid Tests & Point of Care (POC) Pipeline Products by Stage of Development

5 Hemostasis Rapid Tests & Point of Care (POC) Companies and Product Overview
5.1 Atomo Diagnostics Pty Ltd Company Overview
5.1.1 Atomo Diagnostics Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.2 Carclo Diagnostic Solutions Ltd Company Overview
5.2.1 Carclo Diagnostic Solutions Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.3 Cascade Metrix LLC Company Overview
5.3.1 Cascade Metrix LLC Pipeline Products & Ongoing Clinical Trials Overview
5.4 Edan Instruments Inc Company Overview
5.4.1 Edan Instruments Inc Pipeline Products & Ongoing Clinical Trials Overview
5.5 EKF Diagnostics Holdings Plc Company Overview
5.5.1 EKF Diagnostics Holdings Plc Pipeline Products & Ongoing Clinical Trials Overview
5.6 Emosis SAS Company Overview
5.6.1 Emosis SAS Pipeline Products & Ongoing Clinical Trials Overview
5.7 Fraunhofer Institute for Cell Therapy and Immunology Company Overview
5.7.1 Fraunhofer Institute for Cell Therapy and Immunology Pipeline Products & Ongoing Clinical Trials Overview
5.8 Helena Laboratories Corp Company Overview
5.8.1 Helena Laboratories Corp Pipeline Products & Ongoing Clinical Trials Overview
5.9 Universal Biosensors Inc Company Overview
5.9.1 Universal Biosensors Inc Pipeline Products & Ongoing Clinical Trials Overview

6 Hemostasis Rapid Tests & Point of Care (POC) - Recent Developments
6.1 Apr 08, 2019: Aggredyne receives FDA clearance for ADP platelet aggregation testing cartridge
6.2 Nov 22, 2018: EMOSIS reinforces its Intellectual Property and scientific expertise

7 Appendix
7.1 Methodology
7.2 About the author
7.3 Contact Us
7.4 Disclaimer

List of Tables
Table 1: Hemostasis Rapid Tests & Point of Care (POC) Pipeline Products by Stage of Development
Table 2: Hemostasis Rapid Tests & Point of Care (POC) Pipeline Products by Territory
Table 3: Hemostasis Rapid Tests & Point of Care (POC) Pipeline Products by Regulatory Path
Table 4: Hemostasis Rapid Tests & Point of Care (POC) Pipeline Products by Estimated Approval Date
Table 5: Hemostasis Rapid Tests & Point of Care (POC) Companies - Pipeline Products by Stage of Development
Table 6: Hemostasis Rapid Tests & Point of Care (POC) Pipeline Products by Stage of Development
Table 7: Atomo Diagnostics Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 10: Carclo Diagnostic Solutions Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 13: Cascade Metrix LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 16: Edan Instruments Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 19: EKF Diagnostics Holdings Plc Pipeline Products & Ongoing Clinical Trials Overview
Table 22: Emosis SAS Pipeline Products & Ongoing Clinical Trials Overview
Table 25: Fraunhofer Institute for Cell Therapy and Immunology Pipeline Products & Ongoing Clinical Trials Overview
Table 28: Helena Laboratories Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 47: Universal Biosensors Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 50: Glossary

List of Figures
Figure 1: Hemostasis Rapid Tests & Point of Care (POC) Pipeline Products by Stage of Development
Figure 2: Hemostasis Rapid Tests & Point of Care (POC) Pipeline Products by Territory
Figure 3: Hemostasis Rapid Tests & Point of Care (POC) Pipeline Products by Regulatory Path
Figure 4: Hemostasis Rapid Tests & Point of Care (POC) Pipeline Products by Estimated Approval Date

Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Atomo Diagnostics Pty Ltd
  • Carclo Diagnostic Solutions Ltd
  • Cascade Metrix LLC
  • Edan Instruments Inc
  • EKF Diagnostics Holdings Plc
  • Emosis SAS
  • Fraunhofer Institute for Cell Therapy and Immunology
  • Helena Laboratories Corp
  • Universal Biosensors Inc
Note: Product cover images may vary from those shown
Adroll
adroll